Health System Reforms in OECD Countries Lessons for China WHO China - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Health System Reforms in OECD Countries Lessons for China WHO China

Description:

Ambulatory care shifting care to an ambulatory environment helps control ... Strengthen ambulatory care and introduce gate keeping village clinics and urban ... – PowerPoint PPT presentation

Number of Views:36
Avg rating:3.0/5.0
Slides: 27
Provided by: bri120
Category:

less

Transcript and Presenter's Notes

Title: Health System Reforms in OECD Countries Lessons for China WHO China


1
Health System Reforms in OECD Countries Lessons
for ChinaWHO China
http//www.wpro.who.int/china
2
Overview of Presentation
  • OECD Health Systems Reforms - Lessons for China
  • Characteristics of health care systems
  • Financial resources for health care
  • Cost containment initiatives
  • Improving efficiency at the micro level
  • Ensuring equitable access to health care
  • Improving quality of care including patient
    satisfaction
  • Government role in regulating quality, safety and
    cost control
  • Reflections and implications for China

http//www.wpro.who.int/china
3
1. Characteristics of Health Systems in OECD
  • UNIVERSAL coverage of health care
  • with Governments taking major responsibilities
  • Adequate public health financing
  • Via publicly organized social health insurance
    schemes
  • Or via tax-based national health services
  • Private insurance
  • main mode (Swiss, US)
  • - increasing choice timeliness of care (UK,
    Ireland, Australia, etc)
  • The way health systems financed are affecting
    equity
  • Relying on taxes and social insurance, rather
    than OOP
  • more equitable and supports access to care
  • Individual premium and cost sharing (co-payments)
  • May have negative implications on equity in
    health care

4
Characteristics OECD
  • Public-integrated model (Australia, Nordic
    countries, UK pre-1990s)
  • Merging finance with provision run like Govt
    department
  • Staff salary paid and complete population
    coverage
  • Cost control can easily be done
  • Weak incentives to improve efficiency, outputs,
    quality and responsiveness to patient needs
  • Contract (purchasing) model (UK in 1990s, Japan,
    New Zeeland)
  • Contract with public or private health providers
  • More responsive to patient needs
  • More difficult to contain costs
  • Private insurance / provider model (Switzerland
    US)
  • Affordable insurance
  • High degree choice
  • Cost control weak

5
2. Financial resources for health OECD
  • Rapid rise of health expenditure in 1960s and
    1970s
  • After reductions in 1980s, several OECD countries
    have raised their public spending on health in
    the 1990s
  • Total health expenditure (THE) averaged 8.4
    GDP
  • with a range from 2.0 for Turkey to 13.2 for
    the US
  • Public expenditure on health averaged 6.2
    GDP
  • Most EU countries over 6 and the lowest is 4.2,
    in Poland
  • Turkey 1.5 Korea 2.6 US 5.9 of GDP
  • Public share of THE averages nearly 75
  • Surpasses 70 in most EU countries
  • Lowest is 56 in Greece and Switzerland Dutch
    63
  • US and Korea both 44
  • Devoting more of GDP to health care as society
    gets richer not necessarily inappropriate

6
3. Cost containment initiatives - OECD
  • Two major factors driving up health care spending
    in Europe
  • Technology likely explained half of the total
    spending growth
  • Population ageing
  • 1980s European countries used 3 policy sets to
    control cost often in the following order
  • Regulation of prices and volumes of health care
    and inputs
  • Caps on healthcare spending, either overall or by
    sector
  • Shifts of the cost onto the private sector
    through increased but limited cost-sharing

http//www.wpro.who.int/china
7
  • I. Regulation of prices and volumes of
    healthcare and inputs
  • Price controls
  • Wage controls esp. in systems with
    public-integrated systems (Denmark, Finland,
    Ireland, Spain, Sweden, UK)
  • Price and fee controls between purchasers and
    providers (Belgium, France, Luxemburg, Germany,
    Austria, Hungary)
  • Administrative price setting for pharmaceutical
    drugs (all EU countries except Germany and
    Switzerland)
  • Disease Related Grouping (DRG)
  • Price and volume controls
  • Prices adjusted as a function of volume to stay
    within budget (Germany ambulatory care Austria
    hospital care)
  • Reduce marginal costing for additional supply and
    volumes

http//www.wpro.who.int/china
8
  • Cont. I. Regulation of prices and volumes of
    healthcare and inputs
  • Volume controls
  • Limits on entry to medical schools (most EU
    countries)
  • requires human resource planning taking into
    account age related needs increases
  • Technology advances can reduce average length of
    stay in hospitals
  • leading to reduced number of beds per capita
  • - controlling the purchasing of high tech
    equipment
  • The effects of cost control measures undermined
    by providers response
  • Increasing volumes
  • Providing higher cost services
  • Up-rating patient into higher cost
    classifications
  • Shifting services into areas where there are no
    price controls
  • Price and wage controls can have negative
    longer-term effects on supply side
  • Shortage of personnel, affecting flexibility and
    ability to increase supply

http//www.wpro.who.int/china
9
  • II. Budgetary caps
  • Most effective in integrated models (Denmark, NZ,
    UK) or single payer countries (Canada)
  • Budget process holds key to cost controls
  • More effective for hospital sector
  • Indicative budgets/targets in countries with
    social-insurance systems (Belgium, France,
    Luxemburg, Netherlands)
  • Prospective budgets instead of retrospective
    payments (paying provider on FFS)
  • Limit the incentives to improve efficiency
  • III. Shifting cost to private sector
  • Cost sharing esp. in pharmaceuticals through
    non-reimbursable and co-payments
  • Burden those who use services (sick poor) and
    potentially restricting access to services

10
4. Improving efficiency at micro level OECD
  • Ambulatory care shifting care to an ambulatory
    environment helps control overall costs and
    enhance economic and technical efficiency
  • The gate-keeping role of GPs has been encouraged
    in several EU countries (France, Norway, UK)
  • GPs are employed on
  • salaries (Greece, Finland, Iceland), salary-fee
    mix (Norway)
  • salary-capitation mix (Portugal, Spain, Sweden)
  • capitation-fee mix (Austria, Denmark, Ireland,
    Italy, Netherlands, UK)
  • fee for service (Germany)
  • Reliance on fee-for-service may see
    supply-induced demand
  • Growing interest in adopting a mix of different
    provider payment methods

http//www.wpro.who.int/china
11
Improving efficiency at micro level
  • HOSPITAL SECTOR
  • Purchaser (GP fund holders, primary doctors,
    insurers, patient) / provider split
  • Budgetary authorities helps control overall
    costs and enhance efficiency
  • Patients strengthen quality and accessibility
    care
  • Critical issues (1) Purchaser gets adequate
    information (2) Increasing and competing
    providers and insurers (3) Administrative cost
  • Hospital contracting and payment system
  • Global grants/budgets
  • main payment method in public integrated systems
    and direct means to control spending can be
    combined with DRG (price and volume)
  • Bed-day payments (Switzerland) flat rate per
    occupied bed
  • Payments per case (prospectively) such as
    Diagnosis Related Group (DRGs)
  • Fee for service not used in EU as prone to
    supply induced demand
  • Enhancing competition among insurers (Dutch new
    reform)

12
Improving efficiency at micro level
  • Pharmaceutical drugs
  • Strict drug approval process and pre-marketing
    requirements to assess whether products are safe
    cost-effective for use (widespread in EU)
  • Price controls at the wholesale and retail level
    (widespread in EU, convergence in prices across
    EU countries)
  • Distribution of pharmaceuticals governed by
    national regulation with professional bodies,
    health providers and health users
  • Number of pharmaceutical wholesalers has
    decreased
  • Rational use supported by
  • clinical practice guidelines (widespread in EU)
  • prescribing budgets and data to provide feedback
    to individual doctors
  • The degree for cost-sharing for drugs has been
    more widespread than for other components of
    healthcare demand

13
Improving efficiency at micro level
  • Technological change
  • Major impact on health outcome per disease and
    major driver of health spending
  • Pre-marketing controls to determine whether a new
    technology is safe and cost-effective for a
    particular use (widespread in EU)
  • Budget caps make hospitals more selective in
    acquiring new technologies (wide-spread
    similarly, capital charges in UK)
  • Purchase of high technical equipment through
    central committee (Netherlands)

http//www.wpro.who.int/china
14
Ensuring Equitable Access to Health Care OECD
  • Universal coverage as policy objective means that
    everyone gets access to appropriate care when
    they need it and at affordable cost
  • Also adopted by poorer European countries
    (Moldova and Kyrgyztan)
  • (Belgium, Finland, Greece, Portugal, Spain
  • The approach generally used to attain universal
    coverage in European countries has been
  • make insurance coverage compulsory
  • include essential health services the service
    benefit package
  • minimize cost sharing with vulnerable groups
    often been exempted from cost-sharing
  • provider payment methods emphasis is on prepaid
    and pooled contributions and move away from user
    fees

http//www.wpro.who.int/china
15
Cont Ensuring Equitable Access to Health Care
OECD
  • Many countries have found that universal and
    comprehensive insurance coverage is not always
    sufficient to ensure equitable access to health
    services. The following problems need to be
    addressed separately
  • Shortages or maldistribution of providers or
    services
  • Socio-cultural barriers
  • Most OECD and European countries, including some
    of the poorer countries, provide nearly universal
    health coverage to their citizens
  • Out-of-pocket payments of total health spending
    below 23 in most EU countries (and max 33, in
    Switzerland)
  • Out-of-pocket of total household consumption
    below 3 in most EU countries (max is 6, in
    Switzerland)

http//www.wpro.who.int/china
16
Stages of coverage and organisational mechanisms

Reduce out-of-pocket payments and increase
prepayment
Universal
coverage
  • Options
  • Tax-based financing
  • SHI
  • Mix of tax-based financing and various types of
    health insurance

Intermediate stages of
coverage
Mixing community-, cooperative and
enterprise-based health insurance, SHI-type
coverage and limited tax-based financing
Absence of

financial protection
Out-of-pocket spending
http//www.wpro.who.int/china
17
Universal coverage
  • OECD experience suggests that universal coverage
    has potentially many advantages
  • Improve the health and productivity of the
    population by making health services financially
    accessible to all
  • Providing coverage for preventive care can lower
    future expenditures for care
  • Reduce the need to provide for a large array of
    safety-net facilities for sick people who cannot
    afford care
  • Reduce administrative costs because processes
    such as verifying eligibility for the program
    will not be necessary
  • Reduce problems of adverse selection into health
    insurance plans
  • Enhance fairness in society

http//www.wpro.who.int/china
18
6. Improving quality of care and patient
satisfaction OECD
  • Policy-makers in OECD increasingly address issues
    of
  • Inappropriate and poor technical quality of
    health-care services
  • Patient safety and medical errors
  • Increased accountability for quality
  • Improving information systems and make reports
    public on health-care quality and performance of
    hospitals, individual providers, health insurance
    plans to enhance health system performance
  • DRG as a measure of quality (Czech)
  • Funding reward (UK)
  • Standardizing protocols and involvement
    professional associations
  • Mandatory accreditation
  • Setting targets and standards for improvement
  • Formalizing patients rights

19
7. Government role in paying, providing and
regulating OECD
  • Government as the provider payer of services,
    using tax revenues UK, Finland, Denmark,
    Ireland, Sweden, Norway, Spain
  • Government as the payer of services, using tax
    revenues private providers Canada
  • Government oversees the provision payment of
    services by non-profit organizations (sickness /
    insurance funds) which rely on employer
    employee contributions Germany, France,
    Netherlands
  • Government provides safety net for those outside
    private insurance schemes Switzerland
  • Government strongly regulates or oversees
    quality, safety and cost control

http//www.wpro.who.int/china
20
8. Reflections and Implications for China
  • China is weak in regulator function (cost,
    quality, safety)
  • Insurance coverage low with incomplete package
  • Urban 55, employment based commercial and
    non-commercial health insurance
  • Rural 45, voluntary, focus catastrophic
    illness, very low reimbursement level (30)
  • Insurers either way Govt (MoLSS, MCA) or
    scattered rural schemes (RCMS) have limited or no
    negotiation power with provider
  • Provider merely public but salary paid 50 90
    thr. user fees
  • Increasing amounts of clinical care and
    under-providing preventive and basic care
  • Prescribing excessive and unnecessary amounts of
    drugs and diagnostics
  • Cost control measurements difficult due to
    dependency on user fees

http//www.wpro.who.int/china
21
Reflections and implications for China
Resources to Health
  • Health expenditure in China
  • Health expenditure (2000) 45 per capita per
    year
  • Health expenditure (2004) 71 per capita per
    year (5.6 of GDP)
  • Total Health Expenditure (THE)
  • Govt 17 in 2004 vs. 40 in 1980
  • Insurance mainly urban 29 in 2004 vs. 40 in
    1980 (Rural)
  • Individual (HH) 54 in 2004 vs. 20 in 1980
  • Fear that health care cost will reach 8 - 10 of
    GDP in 5 years time without necessarily improving
    quality due to inappropriate mechanisms and tools
    to control costs (price) and quantity (volume)
  • Drugs consist 44 of THE. In OECD this around 15

http//www.wpro.who.int/china
22
Reflections and implications for China
Improving efficiency at micro-level
  • Chinas experience in public spending on Health
  • 68 of public health resources toward hospitals
    for mainly urban residents and insufficient
    public resources go to public goods
  • Local governments in poor areas, which are
    responsible for financing health services, face
    sharp financial constraints and fail to fulfill
    their core public health functions unfunded
    mandates
  • Doctors outnumber nurses
  • No gate keeper and excessively using tertiary
    services, bypassing available health services in
    the community TRUST, increasing cost

http//www.wpro.who.int/china
23
Reflections and implications for China
Ensuring equitable access to healthcare
  • Health services in China are (1) grossly
    under-funded by Govt (2) insurance coverage low
    (3) packages inadequate (4) reimbursement low
    and (5) health workers relying on user fees.
  • This has resulted in
  • Over two thirds of Chinas population need to
    rely on their own pockets to cover the cost of
    medical bills
  • Out-of-pocket spending is 56 of total health
    spending
  • Health care cost main single reason for people
    falling into poverty (30 NHSS 50 DRC report)
  • ACCESSIBILITY TO HEALTH SERVICES VERY LOW Govt
    acknowledges accessibility to Health as key
    problem with around 40 of population lacking
    access to hospital mainly financial

http//www.wpro.who.int/china
24
Lessons for China from OECD
  • Step by step .
  • Clarify vision and strengthen Government role in
    Health
  • Govt to increase public expenditure towards
    public health and to support safety net and
    access to Health for the West and the poor
  • Regulator in safety, quality and cost
  • Senior level endorsement required to guide the
    many actors in Health
  • Consider universal coverage to essential
    services
  • Make health insurance compulsory
  • Improve, expand and integrate current urban,
    rural health insurance, and medical financial
    assistance with focus on ensuring access to
    Health for the low resource areas and safety net
    for the poor.
  • Include essential heath services in package with
    focus on West and the poor

25
Lessons for China from OECD
  • Change the method of provider payment
  • towards prepaid and pooled contributions away
    from user fees
  • Introduce forward looking budget instead of
    retrospective payments
  • Strengthen the role of purchaser of health
    services
  • Put in place cost containment tools and
    mechanisms
  • Regulate price and volume of health care inputs
  • Caps on health care spending
  • Develop National Medicine Policy, registration,
    pricing, distribution, rational use
  • Strengthen ambulatory care and introduce gate
    keeping village clinics and urban community
    health centers
  • Improve quality of health services at lower level
    gain trust

http//www.wpro.who.int/china
26
Lessons for China from OECD
  • Improve quality of health services, especially at
    lower level
  • Standardize treatment protocols
  • Introduce mandatory accreditation
  • Improve reporting system and ,make reports public
    on health care quality
  • Improve quality of staff at lower level
  • Introduce health system indicators that will
    focus on accessibility to quality of health
    services
  • Involve all stakeholders in the process
  • THANK YOU

http//www.wpro.who.int/china
Write a Comment
User Comments (0)
About PowerShow.com